How should a prescription for an estradiol transdermal patch (17‑β estradiol 100 µg/24 h) be written?

How to Write a Prescription for Estradiol 100 µg/24h Transdermal Patch

For a 100 µg/24h estradiol transdermal patch, prescribe: "Estradiol transdermal patch 100 mcg/24 hours, apply one patch twice weekly (every 3-4 days), change patch on the same two days each week (e.g., Sunday and Wednesday), apply to clean, dry skin on buttocks or lower abdomen, rotate application sites." 1

Essential Prescription Components

Drug Name and Dose

• Estradiol transdermal patch 100 mcg/24 hours (also written as 0.1 mg/24 hours)
• This is the higher end of the standard dosing range (50-100 µg/24h) 1

Application Frequency

• Apply twice weekly - patches are typically changed every 3-4 days depending on the specific brand 1, 2
• Specify consistent days (e.g., "Apply on Sunday and Wednesday" or "Apply every Monday and Thursday")
• Some brands may be weekly; verify the specific product's instructions 1

Application Site Instructions

• Apply to clean, dry, intact skin
• Preferred sites: buttocks, lower abdomen, or hip area 3
• Rotate application sites to minimize skin irritation
• Avoid breast tissue, waistline, or areas with skin folds

Quantity to Dispense

• For twice-weekly application: Dispense #8 patches (1-month supply) or #24 patches (3-month supply)
• For weekly application: Dispense #4 patches (1-month supply)

Critical Progestogen Consideration

If the patient has an intact uterus, you MUST also prescribe a progestogen to prevent endometrial hyperplasia and cancer. 1, 2, 4

Progestogen Options (if uterus present):

First choice: Micronized progesterone (MP) - associated with lower cardiovascular and thrombotic risk 1

• Sequential regimen: 200 mg orally or vaginally for 12-14 days every 28 days 1
• Example prescription: "Micronized progesterone 200 mg capsules, take one capsule daily at bedtime on days 1-14 of each month"

Alternative progestogens (if MP unavailable):

• Medroxyprogesterone acetate (MPA): 10 mg daily for 12-14 days per month 1
• Dydrogesterone: 10 mg daily for 12-14 days per month 1

Combined patch option: If available in your region, prescribe combined estradiol + levonorgestrel patches to improve compliance 1

• Sequential: 50 µg estradiol alone for 2 weeks, then 50 µg estradiol + 10 µg levonorgestrel for 2 weeks 1
• Continuous: 50 µg estradiol + 7 µg levonorgestrel continuously 1

Complete Sample Prescription

For patient WITH uterus:

1. Estradiol transdermal patch 100 mcg/24 hours
   Apply one patch twice weekly (every 3-4 days)
   Apply to buttocks or lower abdomen, rotate sites
   Change patch on Sunday and Wednesday
   Dispense: #24 patches (3-month supply)
   Refills: 3

2. Micronized progesterone 200 mg capsules
   Take one capsule by mouth at bedtime
   Days 1-14 of each calendar month
   Dispense: #42 capsules (3-month supply)
   Refills: 3

For patient WITHOUT uterus:

Estradiol transdermal patch 100 mcg/24 hours
Apply one patch twice weekly (every 3-4 days)
Apply to buttocks or lower abdomen, rotate sites
Change patch on Sunday and Wednesday
Dispense: #24 patches (3-month supply)
Refills: 3

Important Clinical Caveats

Dose Adjustment

• The 100 µg dose is appropriate for most adult women requiring hormone replacement 1, 2
• Start lower (50 µg) if: patient is elderly, has cardiovascular risk factors, or is initiating therapy 2
• Titrate based on: symptom control and serum estradiol levels (target varies by indication) 1

Monitoring Requirements

• Reevaluate at 3-6 month intervals to determine if treatment is still necessary 4
• For patients with uterus: investigate any undiagnosed persistent or abnormal vaginal bleeding with endometrial sampling 4
• Adjust dose according to patient's tolerance and symptom control 1

Duration of Therapy

• Use lowest effective dose for shortest duration consistent with treatment goals 4
• For premature ovarian insufficiency: continue until average age of natural menopause (45-55 years) 1
• For menopausal symptoms: attempt to taper at 3-6 month intervals 4

Contraindications to Transdermal Route

• Diffuse cutaneous disorders (e.g., chronic skin conditions) 1
• Patient refusal or poor adherence to patch application 1
• In these cases, switch to oral estradiol 1-2 mg daily 1

Advantages of Transdermal Over Oral

The transdermal route is strongly preferred for patients with: 1, 2

• Cardiovascular risk factors
• History of venous thromboembolism (VTE)
• Hypertension
• Hypertriglyceridemia
• Obesity or metabolic syndrome
• Diabetes
• History of gallbladder disease
• Liver concerns (avoids first-pass hepatic metabolism)

This approach avoids the hepatic first-pass effect that increases SHBG, triglycerides, inflammatory markers, and procoagulant factors seen with oral estrogens 1, 2.